The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes

A Scoping Review

Published in: The Milbank Quarterly, Volume 98, Number 1, pages 57–105 (March 2020). doi: 10.1111/1468-0009.12436

Posted on RAND.org on April 29, 2020

by Amanda Mauri, Tarlise N. Townsend, Rebecca Lee Haffajee

Read More

Access further information on this document at The Milbank Quarterly

This article was published outside of RAND. The full text of the article can be found at the link above.

  • This scoping review reveals a growing literature on the effects of certain state opioid misuse prevention policies, but persistent gaps in evidence on other prevalent state policies remain.
  • Policymakers interested in reducing the volume and dosage of opioids prescribed and dispensed can consider adopting robust prescription drug monitoring programs with mandatory access provisions and drug supply management policies, such as prior authorization policies for high-risk prescription opioids.
  • Further research should concentrate on potential unintended consequences of opioid misuse prevention policies, differential policy effects across populations, interventions that have not received sufficient evaluation (eg, Good Samaritan laws, naloxone access laws), and patient-related outcomes.

Research conducted by

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.